Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 6.43% on an annualized basis producing an average annual return of 16.92%. Currently, Thermo Fisher Scientific
Wall Street Snaps Five-Week Winning Streak, Economic Growth Slows, Inflation Holds Steady In April: This Week In The Market
The U.S. stock market ended a five-week positive streak as investors feared that slowing economic momentum could impact the earnings outlook for American corporations.The U.S. economy grew at an annua
Market Whales and Their Recent Bets on BAC Options
Investors with a lot of money to spend have taken a bearish stance on Bank of America (NYSE:BAC).And retail traders should know.We noticed this today when the trades showed up on publicly available op
Disney, NBCUniversal Said to Hit Stalemate on Hulu Valuation: Report
Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Nasdaq Composite falling around 1% on Friday.Shares of Ambarella, Inc. (NASDAQ:AMBA) rose sharply during Friday's session following strong first-quarter earnings and u
Strike At Exxon Site On Hold: Talks Heat Up Over Severance Packages
A strike at Exxon Mobil Corporation's (NYSE:XOM) petrochemical complex in northern France is reportedly expected to remain suspended through June 4 as talks are held over severance packages.The strike
Hess Shareholders Narrowly Approved Sale to Chevron With 51% Vote
Apple, JPMorgan, Corning And More On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Stephanie Link of Hightower said Apple Inc. (NASDAQ:AAPL) is still down 5% from its highs.Cupertino, California-based Apple plans to overhaul the Siri virtual
Chevron's Gorgon LNG Resumes Full Production After Outage
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,100 Today
Elevance Health (NYSE:ELV) has outperformed the market over the past 15 years by 5.0% on an annualized basis producing an average annual return of 17.09%. Currently, Elevance Health has a market capit
ConocoPhillips Set For Growth With Marathon Oil Acquisition: Analysts Anticipate Accretive Financials And Enhanced Asset Base
Several analysts expressed their views on ConocoPhillips' (NYSE:COP) deal to acquire Marathon Oil Corporation (NYSE:MRO) in an all-stock transaction with an enterprise value of $22.5 billion.Yesterday
In-Depth Examination Of 14 Analyst Recommendations For ConocoPhillips
ConocoPhillips (NYSE:COP) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.In the table below, you'll find a summary of their recent ra
10 Financials Stocks Whale Activity In Today's Session
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth.
World's Smartest Banker Says "Could Be Hell To Pay" If Wall Street's Craze Goes Wrong
To gain an edge, this is what you need to know today. Hell To Pay Please click here for an enlarged chart of iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT). Note the following: TLT moves inverse to
Exxon Shrinks Footprint In Nigeria Despite Renewal Of Lease On Lagos Office: Report
Exxon Mobil Corporation (NYSE:XOM) is renewing a 33-year-old lease on its expansive offices in Lagos's upscale Lekki district.The lease was set to expire on Friday.The move comes after it plans to sca
ConocoPhillips Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/30/2024 39.44% Raymond James $155 → $159 Reiterates Strong Buy → Strong Buy 05/15/2024 22.77% RBC Capit
How Is The Market Feeling About JPMorgan Chase?
JPMorgan Chase's (NYSE:JPM) short percent of float has fallen 4.05% since its last report. The company recently reported that it has 20.21 million shares sold short, which is 0.71% of all regular shar
Beyond The Numbers: 12 Analysts Discuss Elevance Health Stock
Elevance Health (NYSE:ELV) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.In the table below, you'll find a summary of the
Elevance Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/30/2024 28.87% Baird → $649 Initiates Coverage On → Outperform 04/24/2024 16.16% Mizuho $575 → $585 Mai
Palantir, AST SpaceMobile, Salesforce, Disney, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Wednesday, key U.S. indices closed lower, with the Dow Jones Industrial Average declining nearly 1.1% to 38,441.54, the S&P 500 dropping 0.7% to 5,266.95, and the Nasdaq finishing the day down appr